https://invesbrain.com/in-groundbreaking-move-fda-approves-myovants-relugolix-as-the-first-once-a-day-pill-for-advanced-prostate-cancer/
In groundbreaking move, FDA approves Myovant's relugolix as the first once-a-day pill for advanced prostate cancer